Attending The DTRA 2022 Annual Meeting? Visit Clinical ink at Booth #9. During the event, the DTRA member community and leading visionaries in decentralized research […]
Attending Clinical Trials Europe 2022? So is Clinical ink. Gather with us and "Future-Proof Your Strategies to Ensure Clinical Trial Success: Decentralized Trials, Digital Health, […]
Attending the European Site Solutions Summit? So is Clinical ink, as an SCRS Global Impact Partner. The SCRS European Site Solutions Summit is the best […]
Attending the CNS Summit 2022? Clinical ink is an Executive Patron, and will be in attendance, exhibiting, and presenting. Visit us at booth #48 to […]
Attending the Outsourcing in Clinical Trials DACH 2022? Clinical ink will be in attendance, come find us at booth #4. This event will focus on […]
Over four stimulating days of in-depth discussions in 28 different conferences, 3 plenary keynote sessions, the 7th annual Participant Engagement Awards, special cross-department panels, the […]
For the 15th Annual event, the flagship OCT show will focus on providing delegates with practical take-aways and solutions to their most current operational and […]
How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? […]
Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research Parkinson's Disease and Movement Disorder research is accelerating […]
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. […]
For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.
Don't miss Clinical ink Principal Scientist David Anderson on "Predicting ALS Progression in Remote Sensor-Based Assessments" at the International Congress of Parkinson’s Disease and Movement […]
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
